<DOC>
	<DOCNO>NCT02787291</DOCNO>
	<brief_summary>To demonstrate safety efficacy Durata Optisure high voltage lead Ellipse VR ICD MRI environment .</brief_summary>
	<brief_title>A Clinical Evaluation Durata Optisure High Voltage Leads Ellipse VR ICD Undergoing MRI , IDE Study</brief_title>
	<detailed_description>The intent IDE study evaluate safety efficacy Durata Optisure lead Ellipse VR ICD undergone MRI scan . The patient population study include patient indicate implanted Durata Optisure lead Ellipse VR ICD .</detailed_description>
	<criteria>Are implant Durata Optisure lead least 60 day ( include patient Durata Optisure lead &gt; 60 day OR patient new Ellipse VR ICD and/or Durata/Optisure lead implant least 60 day Are implanted Ellipse VR ICD pectorally Be willing undergo elective MRI scan without sedation NOTE : Antianxiety agent ( e.g . minor tranquilizer , etc . ) may use long patient communicate site personnel MRI scan Capture threshold stable &lt; 2.5V @ 0.5ms Ventricular sense measurable ( patient underlie rhythm &gt; 30bpm ) sense amplitude &gt; 4mV Be able provide inform consent study participation ( legal guardian legally authorize representative NOT acceptable ) Be willing able comply prescribe followup test procedure Are contraindicate MRI scan ( per MRI Screening Form ) Have competitor 's MRI compatible endocardial lead implant cap Have another exist active implant medical device , e.g. , neurostimulator , infusion pump , etc. , MR label allow MRI scan per protocol complete . Have lead revision Durata/Optisure lead occur &lt; 60 day baseline visit Have nonMRI compatible device material implanted NOTE : MRI compatible knee replacement , hip replacement , stent , etc . may include long label device allow MRI scan conduct per protocol NOTE : MRI compatible mechanical , prosthetic , bioprosthetic heart valve may include long label device allow MRI scan conduct per protocol NOTE : Nonremovable dental implant may include Have lead extender , adaptor , capped/abandoned lead Enrolled intend participate clinical drug and/or device study ( investigational device , investigational drug , new indication device drug additional test beyond standard care procedure ) , could confound result trial determine SJM . Pregnant plan become pregnant duration subject 's participation study Have life expectancy le 12 month due condition Patients exclusion criterion require local law ( e.g. , age )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>